May Yu
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.4% of the total across 869 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 58 manufacturers, the largest accounting for just 13.5% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 869 payments — averaging $27.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$3K
- AbbVie$2K
- Amgen$2K
- AstraZeneca$2K
- Lilly USA, LLC$1K
- GSK$1K
- plus $12K from 52 others
What the payments were for
- Food & beverage$23,50098%
- Education$3852%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$23,885 in reported general payments places this provider in the 95th percentile of 8,883 family providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 156 | $165,226 |
| OzempicSemaglutide | 68 | $100,209 |
| EliquisApixaban | 92 | $81,776 |
| JardianceEmpagliflozin | 80 | $80,681 |
| RybelsusSemaglutide | 53 | $64,656 |
| TrulicityDulaglutide | 40 | $63,862 |
| JanuviaSitagliptin Phosphate | 43 | $49,450 |
| MounjaroTirzepatide | 45 | $47,458 |
| Repatha SureclickEvolocumab | 35 | $20,692 |
| AptiomEslicarbazepine Acetate | 12 | $15,006 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $14,956 |
| Repatha PushtronexEvolocumab | 19 | $11,103 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 15 | $10,268 |
| VascepaIcosapent Ethyl | 17 | $9,741 |
| LivaloPitavastatin Calcium | 11 | $5,093 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $1,787 | $165,226156 claims |
| Novo NordiskOzempic, Rybelsus | $3,229 | $164,865121 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $1,348 | $111,32085 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $623 | $90,94995 claims |
| PfizerEliquis | $418 | $81,77692 claims |
| MerckJanuvia | $202 | $49,45043 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $78 | $15,00612 claims |
| GSKTrelegy Ellipta | $1,240 | $14,95612 claims |
| Kowa Pharmaceuticals America, Inc.Livalo | $59 | $5,09311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,883 family providers in New York.
Other family in Bronx
- Vladimir ByhovskyBronx$70K
- Daphenie FauvelBronx$21K
- Schevaughn Carr CelestineBronx$20K
- Nighat SaeedBronx$19K
- Keisha BallentineBronx$18K
- Christina NalboneNew York$197K
- Casey GrilloNew York$191K
- Suzanne WilsonIthaca$179K
- Jonathan LesuerSyracuse$172K
- Sheri HillNorth Syracuse$165K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.